On April 1st, this morning, innovative drugs suddenly became the main force of the market. The innovative drug index soared by nearly 6%. Chengda Pharmaceutical, Aidi Pharmaceutical, Poinsettia, Rongchang Bio, Jiankai Technology, Chengdu Pilot and other stocks rose by the limit or rose by more than 10%. Why did this long-dormant sector suddenly explode? Analysts believe that on the one hand, this sector was not a hot spot before, nor was it crowded, and it was also suitable for becoming a defensive variety, so it became the direction of capital attack; on the other hand, it was also related to some sudden positives. First, the State-owned Assets Supervision and Administration Commission of the State Council encouraged state-owned enterprises to carry out mergers and acquisitions in biomedicine and other fields. Second, the expectation of centralized procurement optimization is relatively strong. On March 26, the National Medical Insurance Bureau held a research and development meeting on optimizing the centralized procurement of medicines. The market expectation meeting may promote the detailed rules for the optimization of centralized procurement of medicines. At the same time, the market is also hotly discussing a "plan to further optimize the policy of centralized procurement of medicines (exposure draft) " document. Third, the General Department of the State Food and Drug Administration recently publicly solicited opinions on "measures to optimize the whole life cycle supervision to support the innovative development of high-end medical apparatus (exposure draft) ".
Web3 Desktop Trading Tool
Stay ahead of the game in the cryptocurrency space.